Chronic hepatitis B virus (HBV) infection is a major global public health risk that threatens
human life and health, although the number of vaccinated people has increased. The …

Nonalcoholic fatty liver disease (NAFLD) includes a series of hepatic manifestations, starting
with liver steatosis and potentially evolving towards nonalcoholic steatohepatitis (NASH) …

Itaconate inhibits CD103+ TRM cells and alleviates hepatobil... : Hepatology Itaconate inhibits
CD103+ TRM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing …

Tissue-resident lymphocytes (TRLs) are critical for local protection against viral pathogens in
peripheral tissue. However, it is unclear if TRLs perform a similar role in transplanted organs …

Metabolic dysfunction-associated steatohepatitis (MASH) is the progressed version of
metabolic dysfunction-associated steatotic liver disease (MASLD) characterized by …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases worldwide in recent decades. Metabolic diseases like excessive blood glucose …

The immune mechanism underlying hepatitis B surface antigen (HBsAg) loss, particularly
type I inflammatory response, during pegylated interferon‐α (PEG‐IFN) therapy remains …

Gastrointestinal cancers, which include a variety of esophageal and colorectal
malignancies, present a global health challenge and require effective treatment strategies …

Chronic hepatitis B virus (HBV) infection continues to be a significant public health
challenge, and more than 250 million people around world are infected with HBV. The …

Tissue-resident lymphocytes (TRLs) are noncirculating lymphocytes found in nonlymphoid
tissues, including the kidneys (1–3). Under physiological conditions, TRLs are key players in …